2024 Annual Meeting | C135 - Autoimmune Neurology: Peripheral Nervous System

Date Tuesday 04/16/24

Time 03:30 PM - 05:30 PM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Divyanshu Dubey, MD, FAAN

Topic(s) Autoimmune Neurology

Learning Objectives Participants should be able to identify clinical phenotypes; electrodiagnostic and histopathological features suggestive of serologically defined autoimmune or paraneoplastic neuromuscular presentations be familiar with the current autoantibody testing methodologies, their limitations, and test result interpretation; and learn about therapeutic algorithms based on target-specific immunotherapies for autoimmune neuromuscular disorders.

CME Available 2.00 CME credits

Core Competencies Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Intermediate

Program Tracks Neurohospitalist

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Evaluations

Event Timeline
03:30 PM - 03:40 PM MDT	Speaker	Introduction Divyanshu Dubey, MD, FAAN
03:40 PM - 04:10 PM MDT	Speaker	Expanding List of Clinically Useful Autoantibodies Associated with Autoimmune Neuromuscular Disorders: Through Discovery, Validation, and Clinical Utilization Divyanshu Dubey, MD, FAAN
04:10 PM - 04:15 PM MDT	Speaker	Questions & Answers Divyanshu Dubey, MD, FAAN
04:15 PM - 04:45 PM MDT	Speaker	A Glimpse Inside an Autoimmune Neuromuscular Disorder Testing Laboratory: Methods, Interpretation, Limitations, and Navigating Contradictory Results John R. Mills, MD, PhD
04:45 PM - 04:50 PM MDT	Speaker	Questions & Answers John R. Mills, MD, PhD
04:50 PM - 05:20 PM MDT	Speaker	Advances in the Therapeutic Algorithm for Autoimmune Neuromuscular Disorders Marinos C. Dalakas, MD, FAAN
05:20 PM - 05:25 PM MDT	Speaker	Questions & Answers Marinos C. Dalakas, MD, FAAN
05:25 PM - 05:30 PM MDT	Speaker	Additional Questions for the Panel Divyanshu Dubey, MD, FAAN, John R. Mills, MD, PhD, Marinos C. Dalakas, MD, FAAN

Faculty Disclosures
Divyanshu Dubey, MD, FAAN	The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
John R. Mills, MD, PhD	The institution of Dr. Mills has received research support from Werfen Diagnostics. Dr. Mills has received intellectual property interests from a discovery or technology relating to health care.
Marinos C. Dalakas, MD, FAAN	Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx,. Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.

��ɫ��

��ɫ��